Search
Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...
Tom Goodwyn advises clients on purchasing, selling, financing and leasing commercial real estate. He represents lenders, developers and investors of industrial, office, multi-family housing and hospitality properties across the country. He also counsels clients on land use and zoning matters, either...
David Sugar focuses on real estate and corporate matters, especially the representation of condominium associations and common interest community associations in connection with statutory compliance and governance issues, covenant enforcement, capital project loans, litigation and developer disputes...
Zoning, Land Development and Permitting Every real estate development project starts with a vision, but before construction can begin, land owners and developers must secure government approvals and satisfy neighbor and community concerns, a time-consuming and costly process. In addition, public...
In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Jamie Stevens advises community associations on a range of issues related to their daily business operations, serving as their general legal advisor. In his work with the leaders of condominium and other common interest communities on governing documents, finances, litigation and transactional...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Evan Foster advises clients on legal issues involving technology, data privacy and cybersecurity. Customers and vendors in the health care, life sciences, financial and manufacturing industries, among others, seek his advice on technology transactions and systems acquisition including matters...
Domingos Silva is co-chair of the firm's Intellectual Property Practice with extensive experience in the pharmaceutical, chemical, biotechnology, diagnostics, biochemistry, and materials science areas. Domingos has a Ph.D. in Organic Chemistry from Princeton University and conducted his post...
Kevin T. O'Brien, Ph.D., is a patent agent who focuses his practice on intellectual property (IP) matters including patent preparation and prosecution, patent landscape analyses, and freedom to operate analyses. Kevin practices in the physical and life sciences space, where he works on technologies...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
David Shapiro advises clients on international and domestic business tax planning, including domestic and cross border expansion, joint ventures, mergers, acquisitions, and financing transactions. David's practice includes entity formation and structure planning, securities offerings and hybrid...
Brian Michalek helps companies protect their technological innovations, advances and brand reputation through his intellectual property law practice. As a patent litigator, he has advised clients on a variety of disputes involving software-based technologies, wireless transactions and communications...
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
Adrienne Falde is a member of the Transactional Department in the firm’s Chicago office. She focuses her work on assisting condominium and community associations on issues ranging from compliance with state laws to enforcement of covenants. She also advises associations on how to interpret their...
Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...
Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...
Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...